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Does the Prevention of Complications Explain the Survival
Benefit of Organized Inpatient (Stroke Unit) Care?
Further Analysis of a Systematic Review
Lindsay Govan, BSc, Hons; Peter Langhorne, PhD; Christopher J. Weir, PhD;
for the Stroke Unit Trialists Collaboration
Background and Purpose—Systematic reviews have shown that organized inpatient (stroke unit) care reduces the risk of
death after stroke. However, it is unclear how this is achieved. We tested whether stroke unit care could reduce deaths
by preventing complications.
Methods—We updated a collaborative systematic review of 31 controlled clinical trials (6936 participants) to include
reported interventions and complications during early hospital care plus the certified cause of death during follow up.
Each secondary analysis used data from between 7 and 17 studies (1652 to 3327 participants). Complications were
grouped as physiological, neurological, cardiovascular, complications of immobility, and others. Bayesian hierarchical
models were used to estimate odds ratios for features occurring in stroke units versus conventional care.
Results—Based on the data of 17 trials (3327 participants), organized (stroke unit) care reduced case fatality during
scheduled follow up (OR: 0.75; 95% credible intervals: 0.59 to 0.92), in particular deaths certified as attributable to
complications of immobility (0.59; 0.41 to 0.86). Stroke unit care was associated with statistically significant increases
in the reported use of oxygen (2.39; 1.39 to 4.66), measures to prevent aspiration (2.42; 1.36 to 4.36), and paracetamol
(2.80; 1.14 to 4.83) plus a nonsignificant reduction in the use of urinary catheterization. Stroke units were associated
with statistically significant reductions in stroke progression/recurrence (0.66; 0.46 to 0.95) and in some complications
of immobility: chest infections (0.60; 0.42 to 0.87), other infections (0.56; 0.40 to 0.84), and pressure sores (0.44; 0.22
to 0.85). There were no significant differences in cardiovascular, physiological, or other complications.
Conclusions—Organized inpatient (stroke unit) care appears to reduce the risk of death after stroke through the prevention
and treatment of complications, in particular infections. (Stroke. 2007;38:2536-2540.)
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It has been known for many years that organized inpatient(stroke unit) care reduces the risk of death after stroke,1 but
it is not clear how this benefit is achieved. The Stroke Unit
Trialists Collaboration carried out an analysis 10 years ago
that suggested that stroke units may reduce deaths through
preventing complications.2 However, this analysis had lim-
ited statistical power and its conclusions were speculative.
In the most recent update of the stroke unit systematic
review,3 data were available from a larger number of con-
trolled clinical trials. This allowed us to revisit the question
“does the prevention of complications explain the survival
benefit of stroke unit care?” If this is the case, then we would
expect the following observations to be associated with stroke
unit care: (1) the more frequent use of interventions designed
to prevent complications; (2) a smaller number of recorded
serious complications; and (3) fewer deaths attributed to
complications.
We report a further analysis of the stroke unit review that
addresses these questions.
Methods
Methods of the Review
This is a further analysis of a collaborative systematic review carried
out by the Stroke Unit Trialists Collaboration.3 In summary, this
involved rigorous searching for clinical trials of organized inpatient
(stroke unit) care, the formation of a collaborative group comprising
the primary trialists, the collation of extensive descriptive informa-
tion and outcome data, and the analysis of these data using rigorous
meta-analysis methods. For the current analysis, we used a very
broad definition of stroke unit care and included any trial that
compared organized (stroke unit) care (defined as a multidisciplinary
team specializing in stroke care) versus the contemporary conven-
tional care such as a general medical ward or less organized form of
stroke care. Stroke unit care could include services based in a
discrete ward or provided by a mobile stroke team. In addition to the
existing data, we sought information on the following outcomes: (1)
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specific interventions directed at reducing complications; (2) com-
plications recorded during early hospital care (first 4 weeks); and (3)
certified cause of death during follow up. The exact criteria used
were those defined in the individual trials.
The majority of trials recorded cause of death at the end of
scheduled follow up with the exception of three trials that recorded
at discharge,4–6 three trials that recorded at an earlier fixed time
point,7–9 and one trial with incomplete data.10 The median time for
recorded cause of death was 6 months with an interquartile range of
3 to 12 months.
Complications were classified into four categories to reflect
previous epidemiological work linking complications to cause of
death11: (1) neurological (cerebral edema, stroke recurrence, stroke
progression, seizures, anxiety, depression); (2) cardiovascular com-
plications (myocardial infarction, arrhythmia, congestive cardiac
failure); (3) complications of immobility (chest infection, urinary
tract infection, other infections, dehydration, venous thromboembo-
lism, falls, pressure sores, pain); and (4) other complications (eg,
cancer, gastrointestinal hemorrhage, suicide).
In addition, we also recorded common “physiological complica-
tions,” which were defined as physiological abnormalities that did
not fulfill a conventional medical diagnosis. These included hyper-
tension, hyperglycemia, hypoxia, hypotension, and pyrexia. The
specific definitions of these complications were reported within the
original trials.
The specific interventions directed at reducing complications
included antibiotics, measures to prevent aspiration (systematic
assessment of swallowing and modification of dietary intake), fluids,
insulin, oxygen, paracetamol, tube feeding, and urinary
catheterization.
Statistical Methods
Data were analyzed using a hierarchical Bayesian approach12 in
WinBUGS. A direct random effects model was used to calculate
ORs and 95% credible intervals (CrI). The direct model does not
require the assumption of normality for the raw data because it
allows us to directly model the numbers of patients with particular
outcomes. The assumption of normality can often fail when there are
small numbers of trials or events within trials therefore this is a great
advantage in this analysis. The random effects model allows the
calculated study-specific effects (log ORs) to be different from each
other but assumes they are from a common distribution, in this case
the Normal distribution. In other words, it assumes that all trials are
similar but not identical.13 The fitted model was checked for
adequacy and found to be acceptable. Sensitivity for the range of
assumptions required for this model was also checked.
In addition, absolute risk differences were calculated using the
DerSimonian and Laird14 approach using Revman software.15 This is
a variation on the inverse-variance method that weights trials
according to the extent of variation among treatment effects across
trials.14 The DerSimonian and Laird approach also adjusts the
standard errors of the trial-specific effects to incorporate a measure
of the extent of heterogeneity among treatment effects observed in
different trials.14
Results
The updated systematic review contains 31 controlled clinical
trials (6936 participants).3 A subset of these trials was able to
provide much more detailed data for further analyses as
outlined subsequently. Further details of the included trials
are summarized in a related review.3
Interventions to Prevent Complications
Data were available for seven trials (1652 participants).8,16–21
The results of this analysis are shown in Figure 1, which
indicated that the use of the following interventions were
significantly associated with stroke unit care: measures to
prevent aspiration (OR: 2.4; 95% CrI: 1.4 to 4.4); oxygen
therapy (2.4; 1.4 to 4.7); paracetamol (2.8; 1.1 to 4.8); and
possibly a reduced use of urinary catheter (0.6; 0.3 to 1.1).
Complications During Acute Hospital Stay
Complications data were available for eight trials (1824
participants).6,8,18–23 The main findings are summarized in
Table 1. Statistically significant reductions in complications
were seen in stroke units for the examples of stroke progres-
sion or recurrence, chest infection, other infections, falls, and
pressure sores. None of the recorded physiological compli-
cations were significantly reduced (Figure 2).
Certified Cause of Death
Information on certified cause of death was available for 17
trials (3327 participants).4–10,18,19,21,23–29 Within this group of
trials, organized (stroke unit) care resulted in reduced all-
cause case fatality (OR: 0.75; 95% CrI: 0.59 to 0.92). The
results for certified cause of death are summarized in Table 2
Figure 1. Frequency of intervention use in stroke units and conventional care. Results in plot are presented as (median) ORs of use of
interventions in stroke units versus conventional care. ORs are represented by the shaded diamond with corresponding 95% CrIs rep-
resented by the line. Results are plotted on the log scale.
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and indicated that significant reductions in deaths were
observed for complications of immobility (0.59; 0.41 to 0.86)
but not for any other categories. When these are analyzed as
absolute risk difference, we see that there is a reduction in
deaths attributed to complications of immobility of approxi-
mately one to 2 deaths per 100 patients with stroke.
We carried out sensitivity analysis because Bayesian anal-
yses can be sensitive to the choice of priors and initial values.
The conclusions were unaffected by choice of prior distribu-
tion and initial values.
Discussion
It has been recognized over the last decade that patients who
are managed in an organized inpatient (stroke unit) setting are
more likely to survive, return home, and regain independence
than those managed in conventional care settings.1 However,
there has been considerable uncertainty as to why this benefit
may occur and how stroke unit care could influence out-
comes. In a previous analysis from the Stroke Unit Trialists
Collaboration,2 it was suggested that some of the survival
benefit of stroke unit care may be explained by a reduction in
complications. However, there was limited statistical power
to carry out this analysis. In the current update, we had access
to considerably larger amounts of data, which indicated that
stroke unit care appeared to reduce complications of immo-
bility (in particular, infections), although there were also
reductions in stroke recurrence or progression. The current
analysis suggests that some of these reductions could be
TABLE 1. Comparison of Complications Occurring in Stroke Units Versus Conventional Care
Outcome/Category No. of Events: Stroke Unit (%) No. of Events: Control (%) OR (median) 95% CrI
Neurological
Anxiety or depression 112 (16.7) 132 (19.7) 0.74 (0.27–1.97)
Seizures 15 (2.7) 17 (3.1) 0.86 (0.37–1.95)
Stroke progression or recurrence* 85 (9.4) 121 (13.5) 0.66 (0.46–0.95)
Cardiovascular
Cardiovascular† 83 (14.2) 66 (11.0) 1.52 (0.58–4.54)
Complications of immobility
Chest infection 87 (12.0) 134 (18.6) 0.60 (0.42–0.87)
Other infections‡ 122 (13.5) 201 (21.9) 0.56 (0.40–0.84)
Dehydration 21 (5.1) 43 (10.1) 0.81 (0.31–2.53)
Venous thromboembolism§ 30 (4.4) 35 (5.0) 0.85 (0.49–1.49)
Falls 28 (18.4) 43 (28.3) 0.57 (0.33–0.97)
Pressure sores 21 (4.7) 43 (9.6) 0.44 (0.22–0.85)
Pain 70 (12.1) 71 (12.3) 0.73 (0.14–2.60)
Other complications
Other 22 (2.9) 24 (3.1) 0.95 (0.46–2.10)
Results are presented as ORs with 95% CrI of complications in stroke units versus conventional care.
*Stroke progression and early recurrence were often not distinguished in the original trials.
†Individual cardiovascular complications (eg, ischemic heart disease, arrhythmia) were usually grouped together.
‡Predominantly urinary tract infection.
§Includes deep vein thrombosis and pulmonary embolism.
Figure 2. Frequency of physiological complications in stroke units or conventional care. Results are presented as in Figure 1.
2538 Stroke September 2007
 at GLASGOW UNIV LIB on November 5, 2009 stroke.ahajournals.orgDownloaded from 
explained by a more comprehensive implementation of mea-
sures to prevent complications, in particular, measures to
prevent aspiration, oxygen treatment, and treatment for
pyrexia.
Although our analysis has a number of strengths, in
particular using a much larger data set than previously
available, we must also acknowledge a number of limitations.
First, although we have carried out a pooled analysis of a
number of trials, there is still limited information around
particular complications and CIs are correspondingly broad.
Second, we have used trial data in which some complications
were often not recorded in a blinded fashion and variable
definitions of complications may have been used. For exam-
ple, it was often difficult to distinguish between the compli-
cations of very early stroke recurrence and progression of the
original stroke symptoms. Therefore, the current analysis
may have been subject to observer bias. Similarly, the
information on certified cause of death is frequently not
confirmed by postmortem examination and so could also be
subject to bias. Third, the analysis of complications may be
difficult to interpret. In theory, careful monitoring could
identify and treat more problems than those identified in a
less careful model of care. Fourth, early mobilization and
training was reported as an objective of care in most of the
included trials; however, no standard definition of measuring
mobilization was used. Therefore this potentially important
aspect of care could not be analyzed. Likewise, other com-
ponents of stroke unit care (eg, prompt use of antithrombotic
drugs, improved monitoring) could not individually be ana-
lyzed. Finally, our analysis demonstrates an association
between stroke unit care and reduction in certain complica-
tions but does not explain how this effect was achieved.
Although we propose that stroke unit care may have helped
prevent complications, the picture is likely to be complex and
there are other possibilities. It is plausible that early stroke
unit care could have resulted in patients having less disabling
symptoms and hence were less prone to experience compli-
cations. Physiological consequences of other complications
(for example, pyrexia attributable to aspiration pneumonia)
may cause secondary dysfunction or cell death in the penum-
bral area. In the acute phase of ischemic stroke, this can lead
to stroke progression and worsening of the prognosis. Com-
plications in the chronic phase probably influence mortality
directly. It is also plausible that if patients in stroke units are
less likely to die through other (identified) mechanisms, they
would also be less likely to experience complications asso-
ciated with the last stages of life. Our analysis cannot
conclusively discriminate between these competing
possibilities.
Despite these remaining uncertainties, we conclude that our
findings emphasize the potential importance of complications as
a treatable factor in stroke outcome. Future research should
explore the best ways of preventing and managing specific
complications, particularly those that seem to carry a high risk of
causing harm.
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